Bioperfectus Mass Distribution of Rapid COVID-19 Tests in Israel Begins The demand for rapid tests is expected to go up after the government announced that the mandatory quarantine period for Israelis infected with COVID-19 would be shortened from a week to five days on January 17th, 2022.
Cervical Cancer Awareness Month 2022 Cervical cancer starts in the cells lining the cervix -- the lower part of the uterus (womb). The cervix connects the body of the uterus (the upper part where a fetus grows) to the vagina (birth canal).
Bioperfectus 2021 Special Review: Goodbye 2021, Hello 2022 2021 has been an exceptional year for Bioperfectus. We have successfully achieved many milestones by supplying our molecular diagnostic products to where people need them most. The glorious stories and moments shaped 2021 of Bioperfectus, now come and follow us for our special #2021Review.
Bioperfectus Obtained CE Mark for the SARS-CoV-2 Antigen Rapid Self-test Bioperfectus is pleased to announce that we have obtained CE Mark for our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test).
Bioperfectus Launches a New RT-PCR Kit to Detect COVID-19 New Variant"Omicron" As a leading manufacturer of molecular diagnostic solutions for infectious diseases, Biopertectus is very proud to announce today that the new SARS-CoV-2 Variant Omicron (B.1.1.529) Real-Time PCR Kit is launched globally. With the detection of the mutation sites of H655Y, N679K, P681H, and E484A, this new kit could help to identify the Omicron variant conveniently and effectively.
Bioperfectus Whole Blood DNA Extraction Kit is Available Now! We are proud to inform you that a new member is joining in Bioperfectus extraction solution pipeline.
Declaration on the Effectiveness of Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit against New Variant Omicron The spread of the new variant “Omicron” is faster than expected. The countries and regions with reported Omicron cases on the GISAID website have been increased to twenty-one on Dec. 2, 2021. This data only shows the number of submitted sequenced cases, which may be just the tip of the iceberg.
Registration Updates: Bioperfectus SARS-CoV-2 Antigen Rapid Test was Approved by the Ministry of Health Israel Bioperfectus is proud to announce that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test was approved by the Ministry of Health Israel.
End Inequalities, End AIDS Today, an estimated 37.7 million people are living with HIV at the end of 2020 worldwide, among which 680,000 people died from HIV-related causes.
Be cautious: New COVID-19 variant "Omicron" spreads to more countries Scientists in South Africa on November 24, 2021, identified a concerning new variant of the coronavirus, whose mutations mark a "big jump in evolution" that is driving a spike in new cases.
